Mycapssa Capsule, Delayed Release
Product Images NDC 69880-120

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Mycapssa (NDC 69880-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amryt Pharmaceuticals Designated Activity Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mycapssa 1

The given text is a chemical formula. It represents the composition of a molecule, where H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol is the sequence of amino acids and xCH;COOH is the chemical group attached to the molecule. The value of x is given as 14102.5.*

FDA Label Image

Mycapssa 2

FDA Label Image

Mycapssa 3

FDA Label Image

Mycapssa 4

FDA Label Image

Mycapssa 5

This is a description of a medication called Octreotide that comes in capsules. Each capsule contains 20 mg of Octreotide, provided as Octreotide Acetate. The capsule bottle contains 28 capsules, and there are specific instructions on how to open and close the capsule bottle. The medication is to be taken one hour before eating or at least two hours after eating. There are also identification numbers and expiration dates on the bottle.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.